High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities. [electronic resource]
Producer: 20070912Description: 759-65 p. digitalISSN:- 1432-0584
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm -- drug effects
- Drug Screening Assays, Antitumor
- Female
- Genes, p53
- Humans
- In Situ Hybridization, Fluorescence
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Methylprednisolone -- administration & dosage
- Middle Aged
- Mutation
- Remission Induction
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.